Patient-reported outcomes in patients with type 2 diabetes treated with liraglutide or glimepiride, both as add-on to metformin
Abstract
Patient-reported outcomes for liraglutide or glimepiride on metformin were investigated. Patients’ treatment satisfaction on liraglutide was higher than with metformin alone and comparable with glimepiride
+
metformin. Patients perceived lower frequency of hypoglycaemia than glimepiride
+
metformin and lower frequency of hyperglycaemia than metformin. Impact of weight on quality of life did not differ.
Keywords: Type 2 diabetes, DTSQ, IWQOL-Lite, Liraglutide, Treatment satisfaction
To access this article, please choose from the options below
PII: S1751-9918(10)00048-3
doi:10.1016/j.pcd.2010.04.001
© 2010 Primary Care Diabetes Europe. Published by Elsevier Inc. All rights reserved.
